Edition:
United States

People: Synergy Pharmaceuticals Inc (SGYP.O)

SGYP.O on Nasdaq

3.69USD
25 May 2017
Change (% chg)

$-0.05 (-1.34%)
Prev Close
$3.74
Open
$3.77
Day's High
$3.81
Day's Low
$3.63
Volume
3,768,633
Avg. Vol
6,308,825
52-wk High
$7.15
52-wk Low
$3.35

Denoyer, Bernard 

Mr. Bernard F. Denoyer, CPA, is no longer Senior Vice President - Finance, Secretary of the Company, with effect from July 1, 2017. He served as our Senior Vice President, Finance and Secretary since July 2008. From May 2013 until June 2014, Mr. Denoyer served as Chief Financial Officer of our previously wholly-owned subsidiary, ContraVir Pharmaceuticals, Inc.. From December 2007 until January 2013, Mr. Denoyer also served as Senior Vice President, Finance and Secretary of Callisto Pharmaceuticals, Inc., our former parent company, and from January 2004 to November 2007 Mr. Denoyer served as Callisto’s Vice President, Finance and Secretary. From October 2000 to December 2003, Mr. Denoyer was an independent consultant providing interim CFO and other services to emerging technology companies, including Callisto and certain portfolio companies of Marsh & McLennan Capital, LLC. From October 1994 until September 2000, Mr. Denoyer served as Chief Financial Officer and Senior Vice President at META Group, Inc., a public information technology research company, where he was instrumental in their 1995 IPO. Mr. Denoyer received his bachelor’s degree in Economics from Fairfield University, his M.B.A. in Finance from Columbia Business School and earned his CPA while with Ernst & Young.

Basic Compensation

Total Annual Compensation, USD 276,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 431,434
Fiscal Year Total, USD 707,434

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gary Jacob

4,211,680

Gary Gemignani

--

Marino Garcia

--

Patrick Griffin

1,195,750

Troy Hamilton

1,362,920

Bernard Denoyer

707,434
As Of  30 Dec 2015